2022 | Journey to hypofractionation in radiotherapy for breast cancer: critical reviews for recent updates
| RADIATION ONCOLOGY JOURNAL |
2020 | Kallikrein 5 overexpression is associated with poor prognosis in uterine cervical cancer
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
2018 | Kilovoltage radiotherapy for companion animals: dosimetric comparison of 300 kV, 450 kV, and 6 MV X-ray beams
| JOURNAL OF VETERINARY SCIENCE |
2014 | Knockdown of TWIST1 enhances arsenic trioxide- and ionizing radiation-induced cell death in lung cancer cells by promoting mitochondrial dysfunction | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS |
2021 | Korean clinical practice guideline for pancreatic cancer 2021: A summary of evidence-based, multi-disciplinary diagnostic and therapeutic approaches | PANCREATOLOGY |
2023 | Korean Practice Guidelines for Gastric Cancer 2022: An Evidence-based, Multidisciplinary Approach
| JOURNAL OF GASTRIC CANCER |
2005 | Korean Society for Pediatric Neuro-Oncology Protocol for Germ Cell Tumors
| Korean Journal of Pediatric Hematology-Oncology (대한소아혈액종양학회지) |
2004 | Lack of Correlation Between P-glycoprotein and Chemotherapy Resistance in Nasal NK/T-cell Lymphomas | LEUKEMIA & LYMPHOMA |
2024 | Large Institutional Experience of Early Outcomes and Dosimetric Findings with Postoperative Stereotactic Partial Breast Irradiation in Breast Cancer | RADIOTHERAPY AND ONCOLOGY |
2003 | Lethal hepatic injury by combined treatment of radiation plus chemotherapy in rats with thioacetamide-induced liver cirrhosis | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2024 | Letter to the Editor | RADIOTHERAPY AND ONCOLOGY |
2000 | Leukemic cell line, KG-1 has a functional loss of hOGG1 enzyme due to a point mutation and 8-hydroxydeoxyguanosine can kill KG-1.
| Oncogene |
2024 | Liver-Directed Combined Radiation Therapy for Downstaging Beyond-Milan Hepatocellular Carcinoma to Liver Transplantation | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2020 | Liver-directed combined radiotherapy as a bridge to curative surgery in locally advanced hepatocellular carcinoma beyond the Milan criteria | RADIOTHERAPY AND ONCOLOGY |
2022 | Liver-Directed Concurrent Chemoradiotherapy versus Sorafenib in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
| CANCERS |
2022 | Liver-directed concurrent chemoradiotherapy versus sorafenib in hepatocellular carcinoma with portal vein tumor thrombus | JOURNAL OF CLINICAL ONCOLOGY |
2016 | Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis after Concurrent Chemoradiation Therapy
| YONSEI MEDICAL JOURNAL |
2019 | Local ablative radiotherapy for oligometastatic non-small cell lung cancer
| RADIATION ONCOLOGY JOURNAL |
2014 | Local control may be the key in improving treatment outcomes of esophageal squamous cell carcinoma undergoing concurrent chemoradiation. | DIGESTION |
2005 | Local radiotherapy as a complement to incomplete transcatheter arterial chemoembolization in locally advanced hepatocellular carcinoma | LIVER INTERNATIONAL |